Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Hepatology
Reference10 articles.
1. Toruner, M. et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 134, 929–936 (2008).
2. Lichtenstein, G. R. et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin. Gastroenterol. Hepatol. 4, 621–630 (2006).
3. Beaugerie, L. et al. The use of immunomodulators and biologics in inflammatory bowel diseases (IBD): a cross-sectional French nationwide cohort 2004–2005 [Abstract]. Gastroenterology 130 (4 Suppl. 2), A2 (2006).
4. Kane, S., Khatibi, B. & Reddy, D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am. J. Gastroenterol. 103, 631–636 (2008).
5. Korelitz, B. I., Fuller, S. R., Warman, J. I. & Goldberg, M. D. Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease. Am. J. Gastroenterol. 94, 424–426 (1999).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献